Psychopharmacologic intervention after hemorrhagic basal ganglia damage.
Traumatic brain injury (TBI) can result in cognitive and behavioral impairments such as poor attention, learning, memory and planning ability and uncontrolled crying that can be more persistent problems than the physical disabilities. Cognitive enhancers have been shown to improve cognitive and behavioral impairments in patients with hemorrhagic basal ganglia lesions as well as other forms of TBI. There is little research about the use of cognitive enhancers after hemorrhagic basal ganglia damage. We present a case of a 38 year old male who made significant recovery with the use of cognitive enhancers.
Department of Psychiatry and Psychology, Medical Affairs, Riyadh, Saudi Arabia. rowesie@sbahc.org.sa
Rafat Mohammed
RM
Al Owesie
Catherine Saino
CS
Morton
D000328:Adult; D020145:Basal Ganglia Hemorrhage / Q000150:complications* / Q000188:drug therapy*; D003072:Cognition Disorders / Q000188:drug therapy / Q000209:etiology*; D005702:Galantamine / Q000627:therapeutic use*; D015600:Glasgow Coma Scale; D006801:Humans; D008297:Male; D001523:Mental Disorders; D008774:Methylphenidate / Q000627:therapeutic use*; D009483:Neuropsychological Tests; D018697:Nootropic Agents / Q000627:therapeutic use*; D015898:Tomography Scanners, X-Ray Computed
D018697:Nootropic Agents; D005702:Galantamine; D008774:Methylphenidate